STGN Stratagene Corp (MM)

Stratagene Corporation (Nasdaq:STGN), a developer, manufacturer and marketer of specialized life science research and diagnostic products, today announced the launch of its new online store available for Stratagene customers in North America and Europe. The new online shopping experience includes unique features that enable easy, fast, and convenient ordering for the life science researcher. With a single click, customers can add products to their shopping cart and apply promotional discounts and account specific pricing to their order upon checkout. They can access their past online ordering history and view the shipping availability of Stratagene products, including delivery dates in North America or Europe. "Customers in the life science market are looking for more efficient ways to buy products but also demand the personalized features that they have come to expect from online consumer merchants," said Diane Haines, Stratagene's Director of Marketing Communications and eBusiness. "We view the improvements to our online store as the first step in executing our eBusiness strategy to meet the more demanding needs of our customers." For more information, visit http://www.stratagene.com/shop. About Stratagene Corporation Stratagene is a developer, marketer and manufacturer of specialized life science research and diagnostic products. The Company's life science research unit supports advances in science by inventing, manufacturing and distributing products that simplify, accelerate and improve research. These products are used throughout the academic, industrial and government research sectors in fields spanning molecular biology, genomics, proteomics, drug discovery and toxicology. The Company's diagnostic unit develops and manufactures products for urinalysis, and high quality automated instrument and reagent systems that use blood samples to test for more than 1,000 different allergies and autoimmune disorders. In addition, by combining its expertise in diagnostics and molecular biology, as well as its experience with FDA regulatory procedures, the Company is pursuing opportunities to expand its product portfolio to include molecular diagnostic kits and instrumentation. More information is available at www.stratagene.com.